Literature DB >> 17146290

Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.

Makio Takahashi1, Hirotake Uchikado, Domenico Caprotti, Karen M Weidenheim, Dennis W Dickson, Hanna Ksiezak-Reding, Giulio M Pasinetti.   

Abstract

G-protein coupled receptor kinases (GRKs) constitute a serine/threonine kinase family playing a major role in agonist-induced phosphorylation and desensitization of G-protein coupled receptors. Recently, GRK2 and GRK5 have been demonstrated to phosphorylate alpha-synuclein (Ser129) and other synuclein isoforms. We studied colocalization of GRK2, GRK5, alpha-synuclein, and tau in neurodegenerative disorders characterized by fibrillary tau inclusions and/or alpha-synuclein-enriched Lewy bodies. We found that Lewy bodies were negative for both GRK2 and GRK5 in Lewy body disease (LBD) and LBD mixed with Alzheimer disease (AD + LBD). Instead, GRK2 but not GRK5 colocalized with 40% to 50% of neurofibrillary tangles in AD + LBD and AD brains. In disorders with less prominent alpha-synucleinopathy, neuronal and glial fibrillary tau deposits known to contain distinct subsets of tau isoforms were also positive for GRK2. These deposits included tufted astrocytes and coiled bodies in progressive supranuclear palsy, astrocytic plaques in corticobasal degeneration, and Pick bodies in Pick disease. In addition, paired helical filaments isolated from AD and AD + LBD brains were found to immunogold-label for GRK2, suggesting that GRK2 could be a potential tau kinase associated with fibrillary tau. Our studies indicate that GRK2 is a novel component of neuronal and glial fibrillary tau deposits with no preference in tau isoform binding. GRK2 may play a role in hyperphosphorylation of tau in tauopathies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146290     DOI: 10.1097/01.jnen.0000248542.82681.12

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  5 in total

Review 1.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

Review 2.  Targeting G protein coupled receptor-related pathways as emerging molecular therapies.

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Pharm J       Date:  2013-08-13       Impact factor: 4.330

3.  G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.

Authors:  Thais Rafael Guimarães; Eric Swanson; Julia Kofler; Amantha Thathiah
Journal:  Neuropathol Appl Neurobiol       Date:  2021-07-19       Impact factor: 8.090

Review 4.  Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.

Authors:  Nicolas Dzamko; Jinxia Zhou; Yue Huang; Glenda M Halliday
Journal:  Front Mol Neurosci       Date:  2014-06-24       Impact factor: 5.639

5.  The influence of two functional genetic variants of GRK5 on tau phosphorylation and their association with Alzheimer's disease risk.

Authors:  Yuan Zhang; Jianghao Zhao; Mingkang Yin; Yujie Cai; Shengyuan Liu; Yan Wang; Xingliang Zhang; Hao Cao; Ting Chen; Pengru Huang; Hui Mai; Zhou Liu; Hua Tao; Bin Zhao; Lili Cui
Journal:  Oncotarget       Date:  2017-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.